Healthcare provider profile · identity verified

Heather M Spry, MD

Family Practice · HIGH POINT, NC · NPI 1154432862

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	742	207
Rosuvastatin Calcium	Rosuvastatin Calcium	596	170
Levothyroxine Sodium	Levothyroxine Sodium	562	140
Amlodipine Besylate	Amlodipine Besylate	557	153
Duloxetine Hcl	Duloxetine Hcl	417	84
Gabapentin	Gabapentin	403	87
Omeprazole	Omeprazole	322	90
Metoprolol Succinate	Metoprolol Succinate	297	73
Lisinopril	Lisinopril	293	79
Pantoprazole Sodium	Pantoprazole Sodium	284	79
Ezetimibe	Ezetimibe	268	70
Famotidine	Famotidine	265	73
Losartan Potassium	Losartan Potassium	227	70
Montelukast Sodium	Montelukast Sodium	212	54
Pravastatin Sodium	Pravastatin Sodium	209	60
Metformin Hcl	Metformin Hcl	177	59
Hydrochlorothiazide	Hydrochlorothiazide	173	47
Simvastatin	Simvastatin	173	45
Valsartan	Valsartan	168	50
Alendronate Sodium	Alendronate Sodium	166	50
Trazodone Hcl	Trazodone Hcl	165	40
Bupropion Xl	Bupropion Hcl	163	36
Fluticasone Propionate	Fluticasone Propionate	159	49
Meloxicam	Meloxicam	159	46
Potassium Chloride	Potassium Chloride	150	42
Jardiance	Empagliflozin	143	26
Furosemide	Furosemide	138	41
Escitalopram Oxalate	Escitalopram Oxalate	131	35
Sertraline Hcl	Sertraline Hcl	124	37
Atenolol	Atenolol	123	34
Ozempic	Semaglutide	111	23
Glipizide Er	Glipizide	110	33
Metoprolol Tartrate	Metoprolol Tartrate	110	31
Albuterol Sulfate Hfa	Albuterol Sulfate	96	43
Carvedilol	Carvedilol	89	25
Tamsulosin Hcl	Tamsulosin Hcl	84	22
Alprazolam	Alprazolam	74	23
Buspirone Hcl	Buspirone Hcl	74	17
Synthroid	Levothyroxine Sodium	73	19
Olmesartan Medoxomil	Olmesartan Medoxomil	72	21
Metformin Hcl Er	Metformin Hcl	69	19
Venlafaxine Hcl Er	Venlafaxine Hcl	68	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	65	21
Mirtazapine	Mirtazapine	64	17
Tizanidine Hcl	Tizanidine Hcl	63	23
Doxazosin Mesylate	Doxazosin Mesylate	62	15
Clopidogrel	Clopidogrel Bisulfate	61	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	22
Allopurinol	Allopurinol	58	16
Esomeprazole Magnesium	Esomeprazole Magnesium	58	16
Eliquis	Apixaban	56	14
Pioglitazone Hcl	Pioglitazone Hcl	56	14
Breo Ellipta	Fluticasone/Vilanterol	54	suppressed
Lorazepam	Lorazepam	53	15
Fluoxetine Hcl	Fluoxetine Hcl	52	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	52	16
Clonazepam	Clonazepam	50	12
Hydralazine Hcl	Hydralazine Hcl	50	11
Myrbetriq	Mirabegron	49	suppressed
Klor-Con M20	Potassium Chloride	48	16
Trulicity	Dulaglutide	45	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	45	13
Azelastine Hcl	Azelastine Hcl	44	18
Ipratropium Bromide	Ipratropium Bromide	44	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Celecoxib	Celecoxib	39	11
Fenofibrate	Fenofibrate Nanocrystallized	39	suppressed
Repatha Sureclick	Evolocumab	39	suppressed
Valacyclovir	Valacyclovir Hcl	39	17
Lovastatin	Lovastatin	37	suppressed
Mounjaro	Tirzepatide	37	11
Estradiol	Estradiol	35	17
Pregabalin	Pregabalin	35	12
Zolpidem Tartrate	Zolpidem Tartrate	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	34	11
Aripiprazole	Aripiprazole	33	suppressed
Propranolol Hcl Er	Propranolol Hcl	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Prednisone	Prednisone	31	28
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	25
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Risedronate Sodium	Risedronate Sodium	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	13
Enalapril Maleate	Enalapril Maleate	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Finasteride	Finasteride	21	suppressed
Glipizide	Glipizide	21	suppressed
Nystatin	Nystatin	21	13
Acyclovir	Acyclovir	20	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Torsemide	Torsemide	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Fluconazole	Fluconazole	17	15
Nystop	Nystatin	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Cephalexin	Cephalexin	16	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Linzess	Linaclotide	16	suppressed
Cefdinir	Cefdinir	15	14
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Topiramate	Topiramate	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Steglatro	Ertugliflozin Pidolate	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Azithromycin	Azithromycin	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Prolia	Denosumab	11	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error